Ameriprise Financial Inc Wave Life Sciences Ltd. Transaction History

Ameriprise Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.38 - $6.48 $1,533 - $2,268	-350 Reduced 1.33%	25,994 $129,000
Q1 2024 May 15, 2024	BUY	$3.54 - $6.84 $1,221 - $2,359	345 Added 1.33%	26,344 $162,000
Q4 2023 Feb 14, 2024	BUY	$4.16 - $6.87 $108,155 - $178,613	25,999 New	25,999 $131,000
Q2 2018 Aug 14, 2018	SELL	$33.85 - $50.65 $796,016 - $1.19 Million	-23,516 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$32.45 - $54.7 $763,094 - $1.29 Million	23,516 New	23,516 $943,000

164

117M

148K

109K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.17B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.